Related Experiment Video
Updated: Jul 25, 2026
13:31
A Neonatal Mouse Spinal Cord Compression Injury Model
Published on: March 27, 2016
Scooter injuries: a new pediatric morbidity
M B Abbott1, S A Hoffinger, D M Nguyen
1East Bay Pediatrics, Berkeley and Orinda, California, USA.
Pediatrics
|July 4, 2001
Summary
Scooter use among children leads to frequent injuries, particularly fractures, often occurring soon after use begins. Younger children experienced more severe injuries, highlighting the need for prevention strategies.
Area of Science:
- Pediatric injury epidemiology
- Musculoskeletal trauma in children
- Injury prevention research
Background:
- Scooter popularity has surged, leading to an increase in pediatric injuries.
- Understanding the patterns of scooter-related injuries is crucial for effective prevention.
Purpose of the Study:
- To characterize the types, mechanisms, and treatments of injuries sustained by children using scooters.
- To explore strategies for preventing scooter-related injuries in pediatric populations.
Main Methods:
- Retrospective case series involving 14 children treated by a general pediatrician and orthopedic surgeon.
- Data collection included detailed patient histories and medical record reviews over a 3-month period.
Main Results:
- Fractures were the most common injury, affecting 11 out of 14 children.
- Most injuries (13/14) occurred within the first month of scooter use, with half (7/14) happening on the first day.
- Protective gear was used by only 5 patients, and injuries still occurred on unprotected body parts.
Conclusions:
- Scooter use poses a significant health hazard to children, contributing to a new category of pediatric injuries.
- Injuries are more frequent and severe in younger children and occur early in the scooter use timeline.
- Further research is essential to develop effective methods for preventing or minimizing scooter-related injuries.
Related Concept Videos
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:25Secondary Spinal Cord Injury llI: Pathophysiology
Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...